Tenet Healthcare (THC) reported solid Q2 results but its shares fell amid policy uncertainty around the Affordable Care Act exchanges, RBC Capital Markets said in a note Tuesday.
RBC analysts Ben Hendrix and Michael Murray said Q2 earnings call raised "widespread concern" over the operating backdrop for 2026 around the ACA exchanges, which is impairing visibility for hospital and payors alike into next year.
"We are not surprised to see management withhold preliminary views on 2026," the analysts said.
"Even so, THC remains our top hospital pick on strong
fundamentals, which we believe are not adequately reflected in the current multiple," they added.
RBC kept its $189 price target and outperform rating.
Price: 158.01, Change: +2.04, Percent Change: +1.31
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。